The FDA has approved a label change on the long-acting injectable contraceptive depot medroxyprogesterone acetate, commonly known as Depo-Provera, to warn users of a potential risk of meningioma. The ...
FDA Adds Brain Tumor Warning to Depo-Provera Birth Control Shot THURSDAY, Dec. 18, 2025 (HealthDay News — The U.S. Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a ...
Women who suffered brain tumors (meningiomas) or spinal cord tumors after taking specific Depo-Provera birth control injections should visit www.DepoTumor.com. GREAT ...
Depo Provera Brain Tumor: Medroxyprogesterone acetate, a contraceptive injection containing the hormone progestin, is widely known by its brand name, Depo-Provera. Administered every three months, it ...
According to the Centers for Disease Control and Prevention (CDC), as of 2017, 65.3% of women between the ages of 15 and 49 in the United States use a form of birth control. Of this population, 10.4% ...
Pfizer site manufacturing heparin active pharmaceutical ingredient. Pfizer is a pharmaceutical biotechnology corporation. U.S. government regulators have approved a new brain tumor warning for ...
The U.S. Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a widely used birth control shot made by Pfizer, alerting patients to a possible risk for a type of brain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback